U.S. and Pfizer Are Negotiating Deal for More Vaccine Doses Next Year
By BY SHARON LAFRANIERE, KATIE THOMAS AND NOAH WEILAND
U.S.
https://ift.tt/3p1Y7D3
The Trump administration is discussing helping the drug maker get the raw materials it would need to produce tens of millions of extra doses of its Covid-19 vaccine in the spring.
New York Times
Vaccination and Immunization, Drugs (Pharmaceuticals), United States Politics and Government, Coronavirus (2019-nCoV)
December 16, 2020 at 12:26AM